Key Releases are ad hoc announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
Header
News Archive
News Archive Navigation
icon
News Archive Navigation Language
Language Preferences
Showing 51 results
February 2020
-
In The News
Novartis CEO Vasant Narasimhan on building trust with society
Vas Narasimhan, CEO of Novartis, and CNBC’s Meg Tirrell joins “Closing Bell” in an exclusive interview at the JPMorgan Healthcare Conference. -
In The News
Novartis Pharmaceuticals head on chief, Marie-France Tschudin on rethinking the drug-launch formula
Tschudin talks with FiercePharma at the J.P. Morgan Healthcare Conference.about a “value-based approach” to drug launches.
April 2019
-
In The News
How to be a boss in an unbossed company
In this interview, Novartis CEO Vas Narasimhan sits down with CNNMoney Switzerland’s Urs Gredig and shares why he thinks innovation should come from the bottom and how wearing jeans and no… -
In The News
Medicines and transformative effect
In this Bloomberg interview, Vas Narasimhan, CEO of Novartis shares his thoughts on how medicines can have a transformative effect.
January 2019
-
In The News
Fortune's Most Admired Pharmaceutical Companies 2019
Novartis ranks #4 in Fortune Magazine’s Most Admired Companies Pharmaceutical Industry list. -
In The News
The Science and Business of Innovative Medicines
In this a16z podcast, bio general partners Jorge Conde and Vijay Pande with Sonal Chokshi interview Vas Narasimhan, CEO of Novartis, on some questions, challenges and opportunities that we’re facing…
September 2017
-
In The News
Novartis Access and government of Cameroon sign agreement to fight chronic diseases
Cameroon faces a serious increase in chronic diseases like heart disease, asthma, cancer and diabetes. This agreement complements the government’s ongoing efforts by improving access to affordable… -
In The News
Changing the world
Novartis was ranked 4th in Fortune magazine’s Change the World list and cited for developing an innovative new cancer treatment, working to expand access to healthcare and supporting value-based…